Literature DB >> 28117079

A national dosimetry audit for stereotactic ablative radiotherapy in lung.

Gail Distefano1, Jonny Lee2, Shakardokht Jafari3, Clare Gouldstone4, Colin Baker5, Helen Mayles2, Catharine H Clark6.   

Abstract

BACKGROUND AND
PURPOSE: A UK national dosimetry audit was carried out to assess the accuracy of Stereotactic Ablative Body Radiotherapy (SABR) lung treatment delivery. METHODS AND MATERIALS: This mail-based audit used an anthropomorphic thorax phantom containing nine alanine pellets positioned in the lung region for dosimetry, as well as EBT3 film in the axial plane for isodose comparison. Centres used their local planning protocol/technique, creating 27 SABR plans. A range of delivery techniques including conformal, volumetric modulated arc therapy (VMAT) and Cyberknife (CK) were used with six different calculation algorithms (collapsed cone, superposition, pencil-beam (PB), AAA, Acuros and Monte Carlo).
RESULTS: The mean difference between measured and calculated dose (excluding PB results) was 0.4±1.4% for alanine and 1.4±3.4% for film. PB differences were -6.1% and -12.9% respectively. The median of the absolute maximum isodose-to-isodose distances was 3mm (-6mm to 7mm) and 5mm (-10mm to +19mm) for the 100% and 50% isodose lines respectively.
CONCLUSIONS: Alanine and film is an effective combination for verifying dosimetric and geometric accuracy. There were some differences across dose algorithms, and geometric accuracy was better for VMAT and CK compared with conformal techniques. The alanine dosimetry results showed that planned and delivered doses were within ±3.0% for 25/27 SABR plans.
Copyright © 2017 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Alanine; Audit; Film; Lung; QA; SABR

Mesh:

Year:  2017        PMID: 28117079     DOI: 10.1016/j.radonc.2016.12.016

Source DB:  PubMed          Journal:  Radiother Oncol        ISSN: 0167-8140            Impact factor:   6.280


  6 in total

1.  Adaptation and validation of a commercial head phantom for cranial radiosurgery dosimetry end-to-end audit.

Authors:  Alexis Dimitriadis; Antony L Palmer; Russell A S Thomas; Andrew Nisbet; Catharine H Clark
Journal:  Br J Radiol       Date:  2017-05-25       Impact factor: 3.039

Review 2.  Novel methodologies for dosimetry audits: Adapting to advanced radiotherapy techniques.

Authors:  Marlies Pasler; Victor Hernandez; Núria Jornet; Catharine H Clark
Journal:  Phys Imaging Radiat Oncol       Date:  2018-03-19

3.  The role of dosimetry audit in achieving high quality radiotherapy.

Authors:  Catharine H Clark; Núria Jornet; Ludvig P Muren
Journal:  Phys Imaging Radiat Oncol       Date:  2018-03-21

4.  Development of a physical geometric phantom for deformable image registration credentialing of radiotherapy centers for a clinical trial.

Authors:  Noriyuki Kadoya; Siwaporn Sakulsingharoj; Tomas Kron; Adam Yao; Nicholas Hardcastle; Alanah Bergman; Hiroyuki Okamoto; Nobutaka Mukumoto; Yujiro Nakajima; Keiichi Jingu; Mitsuhiro Nakamura
Journal:  J Appl Clin Med Phys       Date:  2021-06-22       Impact factor: 2.102

5.  Current status of stereotactic ablative body radiotherapy in the UK: six years of progress.

Authors:  Gail Distefano; Satya Garikipati; Helen Grimes; Matthew Hatton
Journal:  BJR Open       Date:  2019-07-19

6.  Dosimetric Impact of Acuros XB Dose-to-Water and Dose-to-Medium Reporting Modes on Lung Stereotactic Body Radiation Therapy and Its Dependency on Structure Composition.

Authors:  Carles Muñoz-Montplet; Rafael Fuentes-Raspall; Diego Jurado-Bruggeman; Sebastià Agramunt-Chaler; Albert Onsès-Segarra; Maria Buxó
Journal:  Adv Radiat Oncol       Date:  2021-05-19
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.